GDTC
CytoMed Therapeutics Ltd.
NASDAQ · Healthcare · Biotechnology · SG
$0.86
−5.49%Leverage
- Debt / equity
- 0.09x
- Net debt / equity
- -0.20x
- Debt / assets
- 0.06x
- Debt / EBITDA
- -0.09x
- Net debt / EBITDA
- 0.21x
Liquidity & coverage
- Current ratio
- 2.64x
- Quick ratio
- 2.64x
- Cash ratio
- 1.19x
- Interest coverage
- -365.88x
- EBITDA / interest
- -309.10x
- Working capital
- $1.6M
Cash & dividend
- FCF / debt
- -13.89x
- Cash flow / debt
- -12.29x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026